Goldman Sachs Group Inc Applied Genetic Technologies Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.62 - $1.1 $56,400 - $100,065
-90,969 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.07 - $2.71 $3,257 - $8,249
3,044 Added 3.46%
90,969 $97,000
Q4 2021

Feb 14, 2022
SELL
$1.87 - $2.91 $42,880 - $66,729
-22,931 Reduced 20.69%
87,925 $167,000
Q3 2021

Nov 10, 2021
BUY
$3.01 - $4.12 $333,676 - $456,726
110,856 New
110,856 $334,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email